• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Acute urinary retention after gonadotropin-releasing hormone agonist treatment for leiomyomata uteri.

作者信息

Friedman A J

机构信息

Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.

出版信息

Fertil Steril. 1993 Mar;59(3):677-8. doi: 10.1016/s0015-0282(16)55821-x.

DOI:10.1016/s0015-0282(16)55821-x
PMID:8458477
Abstract

A case of rapid uterine enlargement and subsequent urinary retention occurring 7 days after GnRH-a administration in a 53-year-old premenopausal woman with myomas is presented. Rapid uterine enlargement was presumed to be caused by hyperestrogenism shortly after GnRH-a administration. The patient was treated with an indwelling Foley catheter for 2 weeks until the uterus decreased to near baseline dimensions. The patient's uterus continued to decrease in size during the 12 weeks she received GnRH-a, and she underwent an uneventful total abdominal hysterectomy and bilateral salpingectomy/oophorectomy after donating 2 units of autologous blood. This case illustrates that adverse effects from GnRH-a treatment may be caused by the transient increase in ovarian steroid secretion shortly after drug administration.

摘要

相似文献

1
Acute urinary retention after gonadotropin-releasing hormone agonist treatment for leiomyomata uteri.
Fertil Steril. 1993 Mar;59(3):677-8. doi: 10.1016/s0015-0282(16)55821-x.
2
A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.一项针对子宫平滑肌瘤女性的促性腺激素释放激素激动剂联合雌激素 - 孕激素或孕激素“反加”方案的前瞻性随机试验。
J Clin Endocrinol Metab. 1993 Jun;76(6):1439-45. doi: 10.1210/jcem.76.6.8501148.
3
Massive ascites after leuprolide acetate administration for the treatment of leiomyomata uteri.
Fertil Steril. 1992 Aug;58(2):416-8. doi: 10.1016/s0015-0282(16)55233-9.
4
Magnetic resonance imaging of leiomyomata uteri: assessing therapy with the gonadotropin-releasing hormone agonist leuprolide.子宫平滑肌瘤的磁共振成像:评估促性腺激素释放激素激动剂亮丙瑞林的治疗效果。
Magn Reson Imaging. 1991;9(3):331-4. doi: 10.1016/0730-725x(91)90419-m.
5
Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist.促性腺激素释放激素激动剂治疗的子宫肌瘤女性子宫体积缩小的预测因素
Fertil Steril. 1992 Aug;58(2):413-5.
6
Gonadotropin-releasing hormone agonist use before hysterectomy.子宫切除术前使用促性腺激素释放激素激动剂。
Am J Obstet Gynecol. 1994 Jun;170(6):1744-8; discussion 1748-51.
7
Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.
Fertil Steril. 1987 Oct;48(4):560-4.
8
Major hemorrhage in a patient with multiple submucous leiomyomata during the treatment of long-acting gonadotropin-releasing hormone agonist.一名患有多发性黏膜下平滑肌瘤的患者在长效促性腺激素释放激素激动剂治疗期间发生大出血。
Kaohsiung J Med Sci. 2000 Feb;16(2):103-7.
9
Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women.低剂量醋酸亮丙瑞林微球治疗日本女性子宫平滑肌瘤的疗效
Fertil Steril. 1992 Jul;58(1):66-71. doi: 10.1016/s0015-0282(16)55138-3.
10
Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.使用促性腺激素释放激素激动剂治疗有症状的围绝经期子宫肌瘤女性。
Taiwan J Obstet Gynecol. 2009 Jun;48(2):133-7. doi: 10.1016/S1028-4559(09)60273-4.

引用本文的文献

1
Urinary retention and uterine leiomyomas: a case series and systematic review of the literature.尿潴留与子宫平滑肌瘤:病例系列及文献系统综述
Int Urogynecol J. 2015 Sep;26(9):1277-84. doi: 10.1007/s00192-015-2665-1. Epub 2015 Mar 10.
2
Drug-induced urinary retention: incidence, management and prevention.药物性尿潴留:发病率、管理与预防
Drug Saf. 2008;31(5):373-88. doi: 10.2165/00002018-200831050-00002.
3
Fibroid-induced acute urinary retention: treatment by uterine artery embolization.子宫肌瘤所致急性尿潴留:子宫动脉栓塞治疗
Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jan;19(1):161-5. doi: 10.1007/s00192-007-0445-2. Epub 2007 Oct 2.
4
Drug-induced bladder and urinary disorders. Incidence, prevention and management.药物性膀胱和泌尿系统疾病。发病率、预防与管理。
Drug Saf. 1998 Jul;19(1):45-55. doi: 10.2165/00002018-199819010-00004.